ATE522221T1 - Verwendung von chitosanen zum erhöhen der nagelwachstumsrate - Google Patents

Verwendung von chitosanen zum erhöhen der nagelwachstumsrate

Info

Publication number
ATE522221T1
ATE522221T1 AT08716765T AT08716765T ATE522221T1 AT E522221 T1 ATE522221 T1 AT E522221T1 AT 08716765 T AT08716765 T AT 08716765T AT 08716765 T AT08716765 T AT 08716765T AT E522221 T1 ATE522221 T1 AT E522221T1
Authority
AT
Austria
Prior art keywords
chitosans
growth rate
nail growth
increase nail
increase
Prior art date
Application number
AT08716765T
Other languages
English (en)
Inventor
Federico Mailland Mr
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38345983&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE522221(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Application granted granted Critical
Publication of ATE522221T1 publication Critical patent/ATE522221T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
AT08716765T 2007-02-14 2008-02-07 Verwendung von chitosanen zum erhöhen der nagelwachstumsrate ATE522221T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07102335A EP1958638A1 (de) 2007-02-14 2007-02-14 Verwendung von Chitosanen zum Erhöhen der Nagelwachstumsrate
PCT/EP2008/051477 WO2008098869A2 (en) 2007-02-14 2008-02-07 Use of chitosans to increase nail growth rate

Publications (1)

Publication Number Publication Date
ATE522221T1 true ATE522221T1 (de) 2011-09-15

Family

ID=38345983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08716765T ATE522221T1 (de) 2007-02-14 2008-02-07 Verwendung von chitosanen zum erhöhen der nagelwachstumsrate

Country Status (31)

Country Link
US (3) US8680074B2 (de)
EP (3) EP1958638A1 (de)
JP (3) JP5426401B2 (de)
KR (2) KR101323762B1 (de)
CN (2) CN102988405A (de)
AR (1) AR065316A1 (de)
AT (1) ATE522221T1 (de)
AU (1) AU2008214693B2 (de)
BR (1) BRPI0807595A2 (de)
CA (1) CA2677715C (de)
CL (2) CL2008000444A1 (de)
CO (1) CO6230979A2 (de)
CY (2) CY1112058T1 (de)
DK (2) DK2377541T3 (de)
EA (2) EA201270116A1 (de)
ES (2) ES2436647T3 (de)
HR (2) HRP20110667T1 (de)
IL (1) IL200269A (de)
MA (1) MA31236B1 (de)
ME (1) ME00830B (de)
MX (1) MX2009008686A (de)
MY (2) MY154499A (de)
NZ (1) NZ578896A (de)
PH (1) PH12014500274A1 (de)
PL (2) PL2117564T3 (de)
PT (2) PT2117564E (de)
RS (2) RS53143B (de)
SI (2) SI2377541T1 (de)
UA (1) UA100011C2 (de)
WO (1) WO2008098869A2 (de)
ZA (1) ZA200905443B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10201490B2 (en) 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
WO2010109423A1 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal antifungal and steroids cream comprising chitosan and a process to make it
CN103987370A (zh) * 2011-10-05 2014-08-13 阿勒根公司 用于增进指甲健康的组合物
WO2013093216A1 (fr) * 2011-12-20 2013-06-27 Laboratoires Urgo Composition topique filmogène et son utilisation pour traiter ou prévenir l'onychophagie
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EP2845597A1 (de) * 2013-09-10 2015-03-11 Polichem S.A. Hydroxypropylchitosan zur Behandlung von Onychomykose
EP2910245A1 (de) * 2014-02-21 2015-08-26 Polichem SA Topische antifungizide Zusammensetzung zur Behandlung von Onychomykose
CN109893472A (zh) * 2019-04-09 2019-06-18 涿州皓原箔业有限公司 一种环保无毒水性卸甲液及其制备方法
ES2834732B2 (es) * 2019-12-17 2022-03-24 Univ Valladolid Solucion acuosa que comprende un complejo de inclusion, metodo de obtencion y su uso para aplicacion en cultivos y la mejora de su rendimiento
CN111388416B (zh) * 2020-02-26 2022-03-08 浙江康德药业集团股份有限公司 一种盐酸利多卡因胶浆剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3541305A1 (de) 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
DE3723811A1 (de) * 1987-07-18 1989-01-26 Wella Ag Nagellack auf der basis von o-benzyl-n-hydroxyalkylchitosanen sowie neue o-benzyl-n-hydroxyalkylderivate des chitosans
CA2008775C (en) 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
ES2101263T3 (es) 1993-02-19 1997-07-01 Howard Green Composiciones que contienen proteinas de corneocitos.
FR2718637A1 (fr) * 1994-04-15 1995-10-20 Oreal Composition cosmétique à appliquer sur l'ongle.
RU2108114C1 (ru) * 1996-12-27 1998-04-10 Товарищество с ограниченной ответственностью Научно-производственное предприятие "Эрлон", Лтд. Биологическая композиция для лечения ран "коллахит"
ITTO980264A1 (it) 1998-03-26 1999-09-26 Silvio Rossi Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica
US6391334B1 (en) * 1999-10-25 2002-05-21 Amway Corporation Barrier-forming composition
DE10035991A1 (de) * 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
SI1455802T1 (sl) * 2001-12-14 2009-06-30 Dnp Canada Inc Uporaba hitozanskih oligosaharidov
EP1440683A1 (de) * 2003-01-23 2004-07-28 Cognis France S.A. Verwendung von Oligoglucosaminen in kosmetischen oder dermatologischen Zubereitungen
EP1491202A1 (de) 2003-06-23 2004-12-29 Polichem S.A. Nagel-restrukturierende Zusammensetzungen zur topischen Applikation
JP3881992B2 (ja) 2004-07-30 2007-02-14 シャープ株式会社 受信装置、受信プログラム、および受信プログラムを記録した記録媒体
WO2006111426A1 (en) * 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
DE102006049585A1 (de) * 2006-10-22 2008-04-24 Susilo, Rudy, Dr. Nagellack für kosmetische und medizinische Anwendungen

Also Published As

Publication number Publication date
CN101663039B (zh) 2013-08-07
WO2008098869A2 (en) 2008-08-21
JP2015221823A (ja) 2015-12-10
JP6045663B2 (ja) 2016-12-14
WO2008098869A3 (en) 2008-10-09
JP5426401B2 (ja) 2014-02-26
PT2117564E (pt) 2011-10-17
KR101131015B1 (ko) 2012-03-29
MY163297A (en) 2017-09-15
EP1958638A1 (de) 2008-08-20
JP2010518138A (ja) 2010-05-27
US20100152133A1 (en) 2010-06-17
IL200269A (en) 2015-10-29
EA018390B1 (ru) 2013-07-30
EP2377541A1 (de) 2011-10-19
NZ578896A (en) 2012-02-24
CA2677715A1 (en) 2008-08-21
ES2369116T3 (es) 2011-11-25
PL2117564T3 (pl) 2012-03-30
AU2008214693A2 (en) 2009-09-10
RS53143B (sr) 2014-06-30
AU2008214693B2 (en) 2013-05-02
PT2377541E (pt) 2013-11-21
SI2377541T1 (sl) 2014-01-31
KR20110075043A (ko) 2011-07-05
ES2436647T3 (es) 2014-01-03
CN102988405A (zh) 2013-03-27
CO6230979A2 (es) 2010-12-20
AU2008214693A1 (en) 2008-08-21
CA2677715C (en) 2014-10-14
US20140147401A1 (en) 2014-05-29
SI2117564T1 (sl) 2011-12-30
CN101663039A (zh) 2010-03-03
US20160015620A1 (en) 2016-01-21
DK2117564T3 (da) 2011-10-17
CL2013002052A1 (es) 2014-02-21
US8680074B2 (en) 2014-03-25
AR065316A1 (es) 2009-05-27
HRP20131175T1 (hr) 2014-01-17
US9173827B2 (en) 2015-11-03
CL2008000444A1 (es) 2008-08-22
EP2377541B1 (de) 2013-10-23
JP2013213048A (ja) 2013-10-17
KR101323762B1 (ko) 2013-11-01
IL200269A0 (en) 2010-04-29
MX2009008686A (es) 2009-08-21
HRP20110667T1 (hr) 2011-10-31
ZA200905443B (en) 2010-10-27
PH12014500274A1 (en) 2016-06-06
DK2377541T3 (da) 2013-11-11
RS52031B (sr) 2012-04-30
MA31236B1 (fr) 2010-03-01
CY1115136T1 (el) 2016-12-14
PL2377541T3 (pl) 2014-04-30
EP2117564B1 (de) 2011-08-31
MY154499A (en) 2015-06-30
ME00830B (me) 2012-03-20
HK1133189A1 (en) 2010-03-19
UA100011C2 (ru) 2012-11-12
KR20090121312A (ko) 2009-11-25
BRPI0807595A2 (pt) 2014-07-22
EA200901093A1 (ru) 2010-02-26
EP2117564A2 (de) 2009-11-18
EA201270116A1 (ru) 2012-06-29
CY1112058T1 (el) 2015-11-04

Similar Documents

Publication Publication Date Title
ATE534294T1 (de) Verwendung von dithiin-tetracarboximiden zum bekämpfen phytopathogener pilze
LTPA2017039I1 (lt) Pirolopirimidino junginiai, kaip CDK inhibitoriai
EP3960854C0 (de) Massenfertigung von löslicher hyaluronidase
SMT201500176B (it) Composizioni e metodi per inibire l'espressione ditranstiretina
HUE043536T2 (hu) PDK1 inhibitorként alkalmazható heterociklusos vegyületek
BRPI0911764A2 (pt) inibidores cíclicos de 11beta-hidroxiesteroide desigrogenase 1
DK2117564T3 (da) Anvendelse af chitosaner til forøgelse af neglevæksthastigheden
ATE523083T1 (de) Erhöhte pflanzenvitalität
LT3150178T (lt) Stimuliavimo aparatas
EP2609107C0 (de) Blocksynthese von oligoribonukleotiden
DK2143429T5 (da) Anvendelse af cilastatin til reduktion af nephrotoksicitet af forskellige forbindelser
BRPI0819633A2 (pt) Métodos para produzir poliolefinas
EP2619333A4 (de) Parallelsequenzierung mit nativer verlängerung
EP2250149A4 (de) Verfahren zur salzherstellung
BRPI0921679A2 (pt) composto útil para tratar celulite
EP2330896A4 (de) Antinekrotische wirkung von alpha 1-antitrypsin
BRPI0915655A2 (pt) método para aumentar o rendimento de cultura
DK2173197T3 (da) Fremgangsmåde
EP2346829A4 (de) Inhibitoren von stat3
IT1393870B1 (it) Procedimento di confezionamento di volatili, in particolare di volatili freschi per aumentare la durata limite di consumazione
ITRA20080006A1 (it) Facciata continua
DK2203170T3 (da) Novel therapeutic uses of adrenergic alfuzosine
EE200800059A (et) K„siaplikaatori kinnitus
UA19301S (uk) Модель штучно нарощуваного нігтя
BRDI7006056S (pt) "configuração aplicada em espargidor"

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2117564

Country of ref document: EP